$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Efficacy, indications and clinical research summary of Tarlatamab-Imdelltra in the treatment of small cell lung cancer
2026-02-01 22:25:32
Check Details
Telisotuzumab-EMRELIS medication precautions and safety and risk tips for long-term use
2026-02-01 22:25:32
Check Details
Possible reactions after discontinuation of tovorafenib and instructions for medication risks and safe discontinuation protocols
2026-02-01 22:25:32
Check Details
How long does it take for vorasidenib-VORANIGO to take effect and analysis of clinical course of treatment, onset of effect and patient experience
2026-02-01 22:25:32
Check Details
Zongatinib (Zongatinib) mechanism of action, pharmacological effects and scientific principles in tumor treatment
2026-02-01 22:25:32
Check Details
Is vosoritide effective for achondroplasia? Analysis of clinical efficacy and patient height improvement data
2026-02-01 22:25:32
Check Details
Methylcobalamin injection (Rozebalamin) latest price reference and application of medical insurance reimbursement policy
2026-02-01 22:25:32
Check Details
Real evaluation of the therapeutic effect of cobimetinib and long-term patient follow-up data
2026-02-01 22:25:32
Check Details
How much does a box of macitentan cost after it is included in medical insurance? List of policy implementation areas
2026-02-01 22:25:32
Check Details
Detailed explanation of the mechanism of action of Tilorisen (Harcos) and its impact on the central arousal system
2026-02-01 22:25:32
Check Details
Pretomanid’s mechanism of action, pharmacological characteristics and scientific analysis of multi-drug-resistant tuberculosis treatment
2026-02-01 22:25:32
Check Details
Tepotinib produces better response in adenocarcinoma versus non-adenocarcinoma MET exon 14 skipped non-small cell lung cancer
2026-02-01 22:25:32
Check Details
1
2
...
2441
2442
2443
2444
2445
2446
2447
...
10214
10215
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
ROS and Cancer: The Potential of Natural Antioxidants
2
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
3
Breaking the Bottleneck: KOSELUGO® (Selumetinib) Reshapes the Treatment Landscape for Neurofibromatosis Type 1 (NF1)
4
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
5
Niraparib: A PARP Inhibitor for Ovarian Cancer Maintenance Therapy
6
Abiraterone Acetate: CYP17 Inhibitor for Advanced Prostate Cancer
7
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
8
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
9
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
10
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
11
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
12
Adagrasib Medication Management Guide for Special Populations